ArticleBreast cancer research : BCR2018

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.

Carla L Alves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.